查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587262

感冒和流感補充品市場：按類型、形式和分銷管道分類 - 2025-2030 年全球預測

Cold & Flu Supplements Market by Type (Herbal Extracts, Homeopathic, Natural Molecules), Form (Pills & Capsules, Powders, Syrups), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年感冒和流感補充品市場價值為167.8億美元，預計到2024年將達到185.7億美元，複合年成長率為10.90%，預計到2030年將達到346.5億美元。

感冒和流感補充品市場包括旨在增強免疫功能並緩解與普通感冒和流感相關症狀的營養產品。這些補充品通常包括維生素、礦物質、草藥和胺基酸，通常用於支持整體免疫健康並減輕症狀的嚴重。這些補充品被認為對於預防病毒感染和更快恢復很重要，尤其是在秋季和冬季等旺季。這些補充品被各種消費群體使用，包括兒童、成人和老年人，最終用戶包括注重健康的人以及尋求傳統藥物之外的替代療法的人。

主要市場統計
基準年[2023] 167.8億美元
預測年份 [2024] 185.7億美元
預測年份 [2030] 346.5億美元
複合年成長率（%） 10.90%

由於健康意識的提高，特別是在最近強調免疫彈性的全球健康危機之後，這個市場正在蓬勃發展。預防保健和天然補充品的趨勢以及線上銷售管道的市場擴張正在推動顯著成長。配方創新和個人化營養的不斷成長趨勢正在為產品開發開闢新途徑，以適應更個人化的消費者體驗。儘管有這些成長要素，市場仍面臨重大挑戰，包括監管障礙、產品功效臨床檢驗的需求以及來自藥品的競爭。消費者對某些補充品功效的懷疑使市場動態更加複雜。

潛在的商機在於研究和創新，特別是開發經過科學證明具有健康益處的補充品。公司可以利用數位平台實施創新行銷策略和消費者教育舉措，從而提高產品可信度。此外，擴展到新興市場使我們能夠接觸到更廣泛的願意投資預防性醫療解決方案的消費者。然而，公司必須保持透明的標籤並收集大量的科學證據，以減少監管挑戰並克服消費者的懷疑。這個市場需要持續創新、消費者參與並專注於紮實的臨床研究，以維持成長並建立消費者對尋求有效健康干預措施的信任。

市場動態：快速發展的感冒和流感補充品市場的關鍵市場洞察

感冒和流感補充品市場正在因供需的動態相互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 老齡化社會中季節性疾病的爆發和對免疫健康的擔憂
    • 透過政府健康計畫和措施提高消費者意識
    • 人們越來越偏好天然和補充品補充品
  • 市場限制因素
    • 藥物替代品的普及
  • 市場機會
    • 不斷推出新開發的增強免疫力的補充品
    • 拓展超級市場及網路銷售管道
  • 市場挑戰
    • 維持產品品質和遵守監管要求的挑戰

波特的五力：駕馭感冒和流感補充品市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解感冒和流感補充品市場的外部影響

外部宏觀環境因素對感冒和流感補充品市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解感冒和流感補充品市場的競爭狀況

對感冒和流感補充品市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣感冒和流感補充品市場供應商的績效評估

FPNV定位矩陣是評估感冒和流感補充品市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，規劃感冒和流感補充品市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對感冒和流感補充品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 季節性疾病爆發和對老年人免疫健康的擔憂
      • 透過政府健康計畫和措施提高消費者意識
      • 對天然和草藥補充品的新偏好
    • 抑制因素
      • 藥物替代品的更廣泛可用性
    • 機會
      • 不斷推出新開發的免疫力增強補充品
      • 拓展超級市場及網上分銷通路
    • 任務
      • 與維持產品品質和遵守監管要求相關的挑戰
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章感冒和流感補充品市場：按類型

  • 草藥萃取物
  • 同類療法
  • 天然分子
  • 維生素和礦物質

第7章感冒和流感補充品市場：按形式

  • 錠劑和膠囊
  • 粉末
  • 糖漿

第8章感冒和流感補充品市場：按分銷管道

  • 線上和電子商務平台
  • 藥局/藥局

第9章北美和南美感冒和流感補充品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太感冒及流感補充品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的感冒和流感補充品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amway International Inc.
  • Bayer AG
  • Church & Dwight Co., Inc.
  • GlaxoSmithKline PLC
  • Haleon PLC
  • Himalaya Global Holdings Ltd.
  • Johnson & Johnson Services Inc.
  • Medique Products
  • Mondelez Global LLC
  • Nature's Sunshine Products, Inc.
  • Nature's Way, Inc.
  • Neurobiologix, Inc.
  • Nutraceutical Corporation
  • Perrigo Company PLC
  • Reckitt Benckiser Group PLC
  • Sambucol by PharmaCare Laboratories Pty Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • The Menarini Group
  • The Procter & Gamble Company
  • Thornton and Ross Limited by STADA Group
  • Wakunaga Pharmaceutical Co., Ltd.
Product Code: MRR-521BAA36EA80

The Cold & Flu Supplements Market was valued at USD 16.78 billion in 2023, expected to reach USD 18.57 billion in 2024, and is projected to grow at a CAGR of 10.90%, to USD 34.65 billion by 2030.

The cold and flu supplements market encompasses nutritional products designed to bolster immune function and alleviate symptoms associated with common colds and flu. These supplements often include vitamins, minerals, herbs, and amino acids, often formulated to support overall immune health and mitigate symptom severity. They are considered critical for preventing viral infections and recovering more swiftly, especially during peak seasons like fall and winter. The application of these supplements extends across different consumer demographics, including children, adults, and the elderly, with end-users ranging from health-conscious individuals to those seeking alternative solutions alongside conventional medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 16.78 billion
Estimated Year [2024] USD 18.57 billion
Forecast Year [2030] USD 34.65 billion
CAGR (%) 10.90%

The market thrives due to increased health awareness, especially after recent global health crises emphasizing immune resilience. The trend towards preventive healthcare and natural supplements has driven significant growth, alongside online sales channels expanding market reach. Innovations in formulation and the growing trend for personalized nutrition are opening new avenues for product development, catering to a more individualized consumer experience. Despite these growth factors, the market faces significant challenges, including regulatory hurdles, the need for clinical validation of product efficacy, and competition from pharmaceuticals. Consumer skepticism regarding the effectiveness of some supplements further complicates market dynamics.

Potential opportunities lie in research and innovation, particularly in the development of scientifically backed supplements with proven health benefits. Companies can leverage digital platforms for innovative marketing strategies and consumer education initiatives that enhance product credibility. Additionally, expanding into emerging markets can provide access to a broader consumer base willing to invest in preventative healthcare solutions. However, companies need to maintain transparency in labeling and gather substantive scientific evidence to mitigate regulatory challenges and overcome consumer skepticism. This market demands continuous innovation, consumer engagement, and a focus on robust clinical research to sustain growth and establish trust among consumers seeking effective health interventions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold & Flu Supplements Market

The Cold & Flu Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Seasonal disease outbreaks and concerns about immune health of aging population
    • Rising consumer awareness through government health programs and initiatives
    • Emerging preferences for natural and herbal supplements
  • Market Restraints
    • Wider availability of pharmaceutical alternatives
  • Market Opportunities
    • Ongoing introduction of newly developed immunity booster supplements
    • Growing expansion of supermarkets and online distribution channels
  • Market Challenges
    • Challenges associated with maintaining product quality and adhering to regulatory requirements

Porter's Five Forces: A Strategic Tool for Navigating the Cold & Flu Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold & Flu Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold & Flu Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold & Flu Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold & Flu Supplements Market

A detailed market share analysis in the Cold & Flu Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold & Flu Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold & Flu Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold & Flu Supplements Market

A strategic analysis of the Cold & Flu Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold & Flu Supplements Market, highlighting leading vendors and their innovative profiles. These include Amway International Inc., Bayer AG, Church & Dwight Co., Inc., GlaxoSmithKline PLC, Haleon PLC, Himalaya Global Holdings Ltd., Johnson & Johnson Services Inc., Medique Products, Mondelez Global LLC, Nature's Sunshine Products, Inc., Nature's Way, Inc., Neurobiologix, Inc., Nutraceutical Corporation, Perrigo Company PLC, Reckitt Benckiser Group PLC, Sambucol by PharmaCare Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., The Menarini Group, The Procter & Gamble Company, Thornton and Ross Limited by STADA Group, and Wakunaga Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cold & Flu Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Herbal Extracts, Homeopathic, Natural Molecules, and Vitamins & Minerals.
  • Based on Form, market is studied across Pills & Capsules, Powders, and Syrups.
  • Based on Distribution Channel, market is studied across Online & E-commerce Platforms and Pharmacies & Drug Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Seasonal disease outbreaks and concerns about immune health of aging population
      • 5.1.1.2. Rising consumer awareness through government health programs and initiatives
      • 5.1.1.3. Emerging preferences for natural and herbal supplements
    • 5.1.2. Restraints
      • 5.1.2.1. Wider availability of pharmaceutical alternatives
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of newly developed immunity booster supplements
      • 5.1.3.2. Growing expansion of supermarkets and online distribution channels
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges associated with maintaining product quality and adhering to regulatory requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cold & Flu Supplements Market, by Type

  • 6.1. Introduction
  • 6.2. Herbal Extracts
  • 6.3. Homeopathic
  • 6.4. Natural Molecules
  • 6.5. Vitamins & Minerals

7. Cold & Flu Supplements Market, by Form

  • 7.1. Introduction
  • 7.2. Pills & Capsules
  • 7.3. Powders
  • 7.4. Syrups

8. Cold & Flu Supplements Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Online & E-commerce Platforms
  • 8.3. Pharmacies & Drug Stores

9. Americas Cold & Flu Supplements Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cold & Flu Supplements Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cold & Flu Supplements Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amway International Inc.
  • 2. Bayer AG
  • 3. Church & Dwight Co., Inc.
  • 4. GlaxoSmithKline PLC
  • 5. Haleon PLC
  • 6. Himalaya Global Holdings Ltd.
  • 7. Johnson & Johnson Services Inc.
  • 8. Medique Products
  • 9. Mondelez Global LLC
  • 10. Nature's Sunshine Products, Inc.
  • 11. Nature's Way, Inc.
  • 12. Neurobiologix, Inc.
  • 13. Nutraceutical Corporation
  • 14. Perrigo Company PLC
  • 15. Reckitt Benckiser Group PLC
  • 16. Sambucol by PharmaCare Laboratories Pty Ltd.
  • 17. Sun Pharmaceutical Industries Ltd.
  • 18. The Menarini Group
  • 19. The Procter & Gamble Company
  • 20. Thornton and Ross Limited by STADA Group
  • 21. Wakunaga Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. COLD & FLU SUPPLEMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. COLD & FLU SUPPLEMENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COLD & FLU SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COLD & FLU SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLD & FLU SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COLD & FLU SUPPLEMENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HOMEOPATHIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY NATURAL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PILLS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE & E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. COLD & FLU SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. COLD & FLU SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023